Akorn Pharmaceuticals

Akorn Investor Relations

SEC Filings

Filing date Form Description Filing Group View
4

Statement of changes in beneficial ownership of securities

3,4,5
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
S-8

Securities offered to employees pursuant to employee benefit plans

Registration Statements
4

Statement of changes in beneficial ownership of securities

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5